International Patent: USE OF GPR55 INHIBITOR IN PREPARATION OF PRODUCT FOR ENHANCING IMMUNE EFFECT ON TUMOR

GENEVA, Oct. 1 -- INSTITUTE OF HEALTH AND MEDICINE, HEFEI COMPREHENSIVE NATIONAL SCIENCE CENTER filed a patent application (CN2026/079559) for “USE OF GPR55 INHIBITOR IN PREPARATION OF PRODUCT FOR ENHANCING IMMUNE EFFECT ON TUMOR”. With publication no. WO/2026/189132, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 45/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....